In conclusion, our experience with the current case suggests that GMA may be useful as remission induction therapy for patients with underlying disorders who have a low
BMD and who cannot be treated with steroids. We recommend further investigations be conducted to establish a detailed consensus concerning the appropriate timing and patient selection for GMA therapy

https://pubmed.ncbi.nlm.nih.gov/33612684/

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_6707-20/_pdf